FI832899A7 - Karsinoembryonaalinen antigeeni, menetelmä sen eristämiseksi ja sen käyttö. - Google Patents

Karsinoembryonaalinen antigeeni, menetelmä sen eristämiseksi ja sen käyttö. Download PDF

Info

Publication number
FI832899A7
FI832899A7 FI832899A FI832899A FI832899A7 FI 832899 A7 FI832899 A7 FI 832899A7 FI 832899 A FI832899 A FI 832899A FI 832899 A FI832899 A FI 832899A FI 832899 A7 FI832899 A7 FI 832899A7
Authority
FI
Finland
Prior art keywords
isolation
carcinoembryonic antigen
carcinoembryonic
antigen
Prior art date
Application number
FI832899A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI832899L (fi
FI832899A0 (fi
Inventor
Rolf Lamerz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI832899A0 publication Critical patent/FI832899A0/fi
Publication of FI832899L publication Critical patent/FI832899L/fi
Publication of FI832899A7 publication Critical patent/FI832899A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00118—Cancer antigens from embryonic or fetal origin
    • A61K39/001182—Carcinoembryonic antigen [CEA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI832899A 1982-08-14 1983-08-11 Karsinoembryonaalinen antigeeni, menetelmä sen eristämiseksi ja sen käyttö. FI832899A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823230299 DE3230299A1 (de) 1982-08-14 1982-08-14 Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung

Publications (3)

Publication Number Publication Date
FI832899A0 FI832899A0 (fi) 1983-08-11
FI832899L FI832899L (fi) 1984-02-15
FI832899A7 true FI832899A7 (fi) 1984-02-15

Family

ID=6170888

Family Applications (1)

Application Number Title Priority Date Filing Date
FI832899A FI832899A7 (fi) 1982-08-14 1983-08-11 Karsinoembryonaalinen antigeeni, menetelmä sen eristämiseksi ja sen käyttö.

Country Status (13)

Country Link
EP (1) EP0102008A3 (en:Method)
JP (1) JPS5950360A (en:Method)
AU (1) AU1796083A (en:Method)
DD (1) DD211714A5 (en:Method)
DE (1) DE3230299A1 (en:Method)
DK (1) DK368783A (en:Method)
ES (1) ES8404187A1 (en:Method)
FI (1) FI832899A7 (en:Method)
GR (1) GR78692B (en:Method)
IL (1) IL69476A0 (en:Method)
NO (1) NO832905L (en:Method)
PT (1) PT77199B (en:Method)
ZA (1) ZA835947B (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317022D0 (en) * 1983-06-23 1983-07-27 Erba Farmitalia Adenocarcinoma related new antigenic determinants
US6013772A (en) * 1986-08-13 2000-01-11 Bayer Corporation Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays
US6949629B2 (en) 2002-03-13 2005-09-27 Aspenbio, Inc. Methods for purifying selected CEA family member proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine

Also Published As

Publication number Publication date
GR78692B (en:Method) 1984-09-27
ES524909A0 (es) 1984-05-01
DD211714A5 (de) 1984-07-25
ZA835947B (en) 1984-04-25
DK368783D0 (da) 1983-08-12
ES8404187A1 (es) 1984-05-01
FI832899L (fi) 1984-02-15
AU1796083A (en) 1985-02-21
JPS5950360A (ja) 1984-03-23
EP0102008A3 (de) 1987-01-28
IL69476A0 (en) 1983-11-30
EP0102008A2 (de) 1984-03-07
PT77199A (de) 1983-09-01
DE3230299A1 (de) 1984-02-16
PT77199B (de) 1986-03-27
NO832905L (no) 1984-02-15
DK368783A (da) 1984-02-15
FI832899A0 (fi) 1983-08-11

Similar Documents

Publication Publication Date Title
FI844288A0 (fi) Antigen modifikation av polypeptider.
DE3382572D1 (de) Antikoerper-verbindungen.
FI812477A7 (fi) Pakkaus ja menetelmä sen valmistamiseksi.
FI810253A7 (fi) Termosähköinen generaattori sekä menetelmä sen muodostamiseksi.
NO880395D0 (no) Antigener.
FI840451A7 (fi) Liimoitusmenetelmä ja -laite.
NL189716C (nl) Diorganopolysiloxanen en werkwijze ter bereiding daarvan.
FI811407A7 (fi) Polyvinyylialkoholi-seos, menetelmä sen valmistamiseksi ja sen käyttö.
FI793338A7 (fi) Siirtotekijä ja menetelmä sen valmistamiseksi.
FI832738A7 (fi) Poimutettu makkarankuori ja menetelmä sen valmistamiseksi.
FI823022A7 (fi) Amino-organoaminosilaanit, niiden valmistusmenetelmä ja niiden käyttö.
DE3583341D1 (de) Leberwurm-antigene.
FI862978L (fi) Onkofetaalisia spesifisiä monoklonaalisia vasta-aineita, menetelmä niiden valmistamiseksi ja niiden käyttö.
FI852701A7 (fi) Panoksen muodostava esikuumennuslaite ja -menetelmä.
FI822031A7 (fi) Päällysvaippa ja menetelmä sen käyttämiseksi.
FI811389A7 (fi) Menetelmä maanalaisen rakenteen valmistamiseksi ja näin aikaasaatu rakenne.
ES522186A0 (es) Metodo de ensayo de anticuerpos.
FI802486A7 (fi) Menetelmä ja laite esineiden kuljettamiseksi.
NO851386L (no) Fremgangsmaate for fremstilling av antigen.
FI843500A7 (fi) Eristevalmiste ja menetelmä sen valmistamiseksi.
FI832899A7 (fi) Karsinoembryonaalinen antigeeni, menetelmä sen eristämiseksi ja sen käyttö.
FI821671A7 (fi) Jauhamismenetelmä.
ES522662A0 (es) Procedimiento para preparar piridil y quinolil-imidazolinonas.
FI862607A7 (fi) Rokote ja menetelmä sen valmistamiseksi.
FI824280L (fi) Ny antigen foer undersoekning av toxoplasmisk immunitet, och foerfarande foer framstaellning av denantigen

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT